Journal profile · OPHTHALMOLOGY
Eye and Vision
ISSN 2326-0254 · BioMed Central · Netherlands · Founded 2014
Eye and Vision: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.21; fully open access; APC about USD 2,790; median 149 days to acceptance (96 articles, last 24 months); 51 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Eye and Vision is published by BioMed Central and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Corneal surgery and disorders, Ophthalmology and Visual Impairment Studies and Glaucoma and retinal disorders, together about 47.3% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging and Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
Eye and Vision is an open access, peer-reviewed journal for ophthalmologists and visual science specialists. It welcomes research articles, reviews, commentaries, case reports, perspectives and short reports encompassing all aspects of eye and vision. Topics of interest include but are not limited to: current developments of theoretical, experimental and clinical investigations in ophthalmology, optometry and vision science which focus on novel and high-impact findings on central issues pertaining to biology, pathophysiology and etiology of eye diseases as well as advances in diagnostic techniques, surgical treatment, instrument updates, the latest drug findings, results of clinical trials and research findings. It aims to provide ophthalmologists and visual science specialists with the latest developments in theoretical, experimental and clinical investigations in eye and vision.
From the journal's Aims & Scope
Research area (LetPub): OPHTHALMOLOGY
Editor-in-chief Jia QuPublisher website
Editorial board by country: 2 in mainland China (about 5%); most named United States 17, Hong Kong, China 3, United Kingdom 3, Italy 3, Canada 3 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Corneal surgery and disordersMedicine17.6%
- Ophthalmology and Visual Impairment StudiesMedicine16.6%
- Glaucoma and retinal disordersMedicine13.1%
- Ocular Surface and Contact LensMedicine8.1%
- Retinal Diseases and TreatmentsMedicine7.5%
- Intraocular Surgery and LensesMedicine6.7%
- Corneal Surgery and TreatmentsMedicine6.4%
- Retinal and Macular SurgeryMedicine5.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Ophthalmology | Zone 1 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Ophthalmology | Zone 1 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Ophthalmology | Zone 1 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CASCurrent ContentsPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.21LetPub ·
- Impact factor (publisher) 2025
- 5.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.4Publisher website ·
- CiteScore 2026-06
- 8.5LetPub ·
- SJR 2026-06
- 1.69LetPub ·
- SNIP 2026-06
- 1.98LetPub ·
- h-index
- 58OpenAlex ·
- i10-index
- 303OpenAlex ·
- 2-year mean citedness
- 5.62OpenAlex ·
- Self-citation rate
- 1.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 50LetPub ·
- Downloads per year (publisher) 2025
- 579,200Publisher website ·
Articles by year OpenAlex count · 508 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 40 | 21 |
| 2025 | 51 | 51 | 228 |
| 2024 | 49 | 49 | 538 |
| 2023 | 50 | 50 | 851 |
| 2022 | 46 | 46 | 1,095 |
| 2021 | 48 | 48 | 1,416 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
149 daysMedian, submission to acceptance · P25–P75 123 days – 181 days
- Acceptance to online
- median 26 days (96 articles)
- Submission to online
- median 182 days
- Sample
- 96 articles with submission and acceptance dates (100 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,290 / USD 2,790 / GBP 1,990 | Yes | CC BY, CC0 | |
| OpenAlex | USD 2,790 / EUR 2,290 / GBP 1,990 | — | — | |
| LetPub | GBP 1,790 / USD 2,590 / EUR 2,090 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- Netherlands
- Language
- English
- Founded
- 2014
- ISSN
- 2326-0254
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Eye and Vision
What CAS zone is Eye and Vision in?
In the 2025 upgraded edition of the CAS Journal Ranking, Eye and Vision is in Zone 2 of Medicine, and in Zone 1 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Eye and Vision?
The latest impact factor listed by LetPub is 5.21; CiteScore 8.5, h-index 58.
How long does peer review take at Eye and Vision?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 149 days (interquartile range 123–181 days); authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Eye and Vision based?
Of the 41 board members whose country the journal's board page names, 2 (about 5%) are in mainland China; the countries named most often are United States (17), Hong Kong, China (3) and United Kingdom (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Eye and Vision?
According to LetPub and DOAJ records, Eye and Vision is indexed in SCIE, Scopus and DOAJ. The journal's website also lists CAS and Current Contents; that list has not been checked against each database.
Is Eye and Vision open access, and what is the APC?
Eye and Vision is a fully open-access journal. APC about USD 2,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .